HCW Biologics Inc.
General ticker "HCWB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $363.5M (TTM average)
HCW Biologics Inc. does not follow the US Stock Market performance with the rate: -29.6%.
Estimated limits based on current volatility of 2.3%: low 1.99$, high 2.08$
Factors to consider:
- Total employees count: 45 (+2.3%) as of 2023
- Top business risk factors: Operational and conduct risks, Going concern, Product development risks, Market acceptance, Manufacturing risks
- Current price 76.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.63$, 26.84$]
- 2025-12-31 to 2026-12-31 estimated range: [8.13$, 24.52$]
Financial Metrics affecting the HCWB estimates:
- Negative: with PPE of -4.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.18 <= 0.33
- Negative: Shareholder equity ratio, % of -22.39 <= 18.93
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of -0.04 > -0.66
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term HCWB quotes
Long-term HCWB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6.72MM | $2.84MM | $2.57MM |
| Operating Expenses | $21.80MM | $28.56MM | $32.05MM |
| Operating Income | $-15.08MM | $-25.72MM | $-29.48MM |
| Non-Operating Income | $0.18MM | $0.72MM | $-0.54MM |
| Interest Expense | $0.13MM | $0.28MM | $1.16MM |
| R&D Expense | $9.34MM | $7.68MM | $6.39MM |
| Income(Loss) | $-14.90MM | $-24.99MM | $-30.02MM |
| Profit(Loss)* | $-14.90MM | $-24.99MM | $-30.02MM |
| Stockholders Equity | $37.43MM | $13.46MM | $-6.77MM |
| Inventory | $1.39MM | $0.00MM | $0.00MM |
| Assets | $46.81MM | $28.51MM | $30.24MM |
| Operating Cash Flow | $-10.39MM | $-22.51MM | $-14.23MM |
| Capital expenditure | $10.28MM | $6.20MM | $0.26MM |
| Investing Cash Flow | $14.71MM | $3.80MM | $-0.26MM |
| Financing Cash Flow | $6.27MM | $-0.01MM | $15.57MM |
| Earnings Per Share** | $-0.42 | $-0.70 | $-0.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.